OBSERVATIONAL STUDY on VIRAL SHEDDING and IMMUNOLOGICAL RESPONSE of OROPOUCHE VIRUS

Launched by IRCCS SACRO CUORE DON CALABRIA DI NEGRAR · Mar 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how the body responds to the Oropouche Virus (OROV) and how long the virus can be found in the body after someone is infected. The researchers will look at blood and other samples from participants to better understand the immune response and the duration of the virus in the body. This study is currently recruiting participants aged 18 and older who have tested positive for the virus.

To participate, individuals need to agree to take part in the study and allow their leftover samples to be used for research. It's important that participants provide informed consent, which means they understand what the study involves and agree to it. If you join the study, you can expect to provide samples during the study period, and your participation will help improve understanding of Oropouche Virus infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients resulted positive to the RT-PCR for OROV;
• • informed consent to the participation to the study and to personal data's treatment and/or donation of residual samples to Tropika Biobank;
• • patients ≥ 18 years old.
• • Exclusion Criteria
• • • lack of signed informed consent.